title: Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Behçet's disease.
authors.affiliation: Center of Rheumatology, Klinikum der J. W. Goethe-Universität, Frankfurt am Main, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Behrens
authors.forename: T
authors.initials: T
authors.lastname: Zollner
authors.forename: B
authors.initials: B
authors.lastname: Moeller
authors.forename: J P
authors.initials: JP
authors.lastname: Kaltwasser
authors.forename: R
authors.initials: R
authors.lastname: Kaufmann
authors.forename: F R
authors.initials: FR
authors.lastname: Ochsendorf
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D005260:Female; D005858:Germany; D006115:Greece / Q000208:ethnology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha